Evidence map›Paper›PMID 23399714›Full record

ArticleHypertension (Dallas, Tex. : 1979)2013

Abnormal aldosterone physiology and cardiometabolic risk factors.

Anand Vaidya, Patricia C Underwood, Paul N Hopkins, Xavier Jeunemaitre, Claudio Ferri, Gordon H Williams, Gail K Adler

Registry-linked trialOpen access · bronzeAbstract readComparative StudyMulticenter Study
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03683069 (Hypertension and Striatin Gene Structure Related to Aldo Phenotype), which is not on this map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03683069 phase4completednot on this mapstarted 2019, after this paper: background citation

Hypertension and Striatin Gene Structure Related to Aldo Phenotype

TypeinterventionalSponsorBrigham and Women's HospitalRan2019 to 2024Enrolled90ConditionsHypertension, Genetics HypertensionArmsEplerenone vs Amlodipine
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Characterizing the Origins of Primary Aldosteronism.Hypertension (Dallas, Tex. : 1979) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Primary Aldosteronism: State-of-the-Art Review.American journal of hypertension · 2022
    Article
  11. Primary aldosteronism - a multidimensional syndrome.Nature reviews. Endocrinology · 2022
    Review
  12. Article
  13. Article
  14. Evolution of the Primary Aldosteronism Syndrome: Updating the Approach.The Journal of clinical endocrinology and metabolism · 2020
    Review
  15. Interplay Between Statins, Cav1 (Caveolin-1), and Aldosterone.Hypertension (Dallas, Tex. : 1979) · 2020 · on this map
    Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Anand VaidyaDivision of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Boston, MA 02115, USA. avaidya1@partners.org
Patricia C Underwood
Paul N Hopkins
Xavier Jeunemaitre
Claudio Ferri
Gordon H Williams
Gail K Adler
Inserm · FRUniversity of Utah · US

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
Zoledronic Acid in Treatment of Osteoporosis in PostmenoM01RR002635 · NCRR · BRIGHAM AND WOMEN'S HOSPITAL · PI GARBER, JUDY E. · 1985 to 2008
$48.4M
Informatics for Integrating Biology/ the Bedside (RMI)U54LM008748 · NLM · BRIGHAM AND WOMEN'S HOSPITAL · PI KOHANE, ISAAC S. · 2004 to 2013
$39.0M
SCOR MOLECULAR GENETICS OF HYPERTENSIONP50HL055000 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WILLIAMS, GORDON H · 1996 to 2005
$13.5M
TRAINING PROGRAM IN HYPERTENSIONT32HL007609 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ADLER, GAIL KURR · 1985 to 2022
$10.2M
Striatin, Aldosterone and HypertensionR01HL114765 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GARZA, AMANDA ELIZABETH, WILLIAMS, GORDON H · 2013 to 2017
$4.3M
Role of Mineralocorticoid Receptor in Diabetic Cardiovascular DiseaseR01HL087060 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ADLER, GAIL KURR · 2008 to 2011
$2.5M
Caveolin-1 and vascular dysfunctionR01HL104032 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI POJOGA, LUMINITA · 2010 to 2014
$2.1M
Aldosterone and Diabetic Cardiovascular Disease: Research and Mentoring ProgamK24HL103845 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ADLER, GAIL KURR · 2011 to 2021
$1.6M
VASCULAR DISEASE IN HBP--ANGII, PAI1, INSULIN AND GENESR01HL059424 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WILLIAMS, GORDON H · 1998 to 2001
$966k
Vitamin D and Hormonal Mechanisms of Cardiovascular Disease in ObesityK23HL111771 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI VAIDYA, ANAND · 2012 to 2016
$805k
Association of the Caveolin Gene with Insulin Resistance and HypertensionF31NR011108 · NINR · BOSTON COLLEGE · PI UNDERWOOD, PATRICIA CROWLEY · 2008 to 2010
$80k
NCRR NIH HHS M01 RR002635NCRR NIH HHS M01-RR02635NCRR NIH HHS UL1 RR025758NCRR NIH HHS UL1RR025758NHLBI NIH HHS HL59424NHLBI NIH HHS K23 HL111771NHLBI NIH HHS K23 HL111771-01NHLBI NIH HHS K24 HL103845NHLBI NIH HHS L30 HL104553NHLBI NIH HHS P50 HL055000NHLBI NIH HHS P50HL055000NHLBI NIH HHS R01 HL047651NHLBI NIH HHS R01 HL087060NHLBI NIH HHS R01 HL104032NHLBI NIH HHS R01 HL114765NHLBI NIH HHS T32 HL007609NINR NIH HHS F31 NR011108NINR NIH HHS F32 NR013318NLM NIH HHS U54 LM008748NLM NIH HHS U54LM008748
6 · The paper itself

Abstract

Abnormal aldosterone physiology has been implicated in the pathogenesis of cardiometabolic diseases. Single aldosterone measurements capture only a limited range of aldosterone physiology. New methods of characterizing aldosterone physiology may provide a more comprehensive understanding of its relationship with cardiometabolic disease. We evaluated whether novel indices of aldosterone responses to dietary sodium modulation, the sodium-modulated aldosterone suppression-stimulation index (SASSI for serum and SAUSSI for urine), could predict cardiometabolic risk factors. We performed cross-sectional analyses on 539 subjects studied on liberal and restricted sodium diets with serum and urinary aldosterone measurements. SASSI and SAUSSI were calculated as the ratio of aldosterone on liberal (maximally suppressed aldosterone) to the aldosterone on restricted (stimulated aldosterone) diets and associated with risk factors using adjusted regression models. Cardiometabolic risk factors associated with either impaired suppression of aldosterone on liberal diet, or impaired stimulation on restricted diet, or both; in all of these individual cases, these risk factors associated with higher SASSI or SAUSSI. In the context of abnormalities that constitute the metabolic syndrome, there was a strong positive association between the number of metabolic syndrome components (0-4) and both SASSI and SAUSSI (P<0.0001) that was independent of known aldosterone secretagogues (angiotensin II, corticotropin, potassium). SASSI and SAUSSI exhibited a high sensitivity in detecting normal individuals with zero metabolic syndrome components (86% for SASSI and 83% for SAUSSI). Assessing the physiological range of aldosterone responses may provide greater insights into adrenal pathophysiology. Dysregulated aldosterone physiology may contribute to, or result from, early cardiometabolic abnormalities.

Indexed as

AldosteroneCross-Sectional StudiesFemaleHumansHypertensionIncidenceMaleMetabolic SyndromeMiddle AgedReninRisk FactorsUnited StatesAldosteroneRenin

Identifiers

PMID23399714
PMCPMC3615445
OpenAlexW2156119953

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.